0.5501
price down icon10.83%   -0.0668
after-market After Hours: .54 -0.0101 -1.84%
loading

X 4 Pharmaceuticals Inc Stock (XFOR) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
47.98%
37.29
25.20 27.21 25.80 29.30
Interest Income/Expense
0.64%
1.874
1.886 1.634 1.148 1.109
Operating Income/Loss
47.98%
-37.29
-25.20 -27.21 -25.80 -29.30
Nonoperating Income/Loss
336.94%
-14.46
6.102 24.93 -29.89 5.288
Income/Loss From Continuing Operations Before Tax
170.97%
-51.75
-19.10 -2.279 -55.70 -24.02
Income Tax Expense/Benefit
42.42%
0.019
0.033 0.026 0.015 0.004
Income/Loss From Continuing Operations After Tax
170.60%
-51.77
-19.13 -2.305 -55.71 -24.02
Net Income/Loss
170.60%
-51.77
-19.13 -2.305 -55.71 -24.02
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,732%
199.99
7.0615 196.99 168.74 145.97
Diluted Average Shares
2,732%
199.99
7.0615 196.99 168.74 145.97
Basic Earnings Per Share
188.89%
-0.26
-0.09 -0.01 -0.33 -0.16
Diluted Earnings Per Share
188.89%
-0.26
-0.09 -0.01 -0.33 -0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):